2024MAY10: Our hosting provider is experiencing intermittent networking issues. We apologize for any inconvenience.

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Activation of transient receptor potential vanilloid 3 channel suppresses adipogenesis.

Endocrinology | 2015

The present study shows that activation of the transient receptor potential vanilloid 3 channel (TRPV3) suppresses adipocyte differentiation. We also found that a major functional catechin compound in green tea and cocoa, (-)-epicatechin, exerts antiadipogenic effects in the adipocytes through direct activation of TRPV3. TRPV3 was detected in the 3T3-L1 adipocytes using immunohistochemistry and semiquantitative PCR. TRPV3 activation by activators (-)-epicatechin and diphenylborinic anhydride was determined using live cell fluorescent Ca(2+) imaging and patch-clamp electrophysiology. Using RNA interference, immunoblotting, and Oil red O staining, we found that the TRPV3 agonists prevented adipogenesis by inhibiting the phosphorylation of insulin receptor substrate 1, the downstream phosphoinositide 3-kinase/Akt/forkhead box protein O1 axis, and the expression of the adipogenic genes peroxisome proliferator-activated receptor γ and CCAAT/enhancer-binding protein α. TRPV3 overexpression hindered adipogenesis in the 3T3-L1 cells. In vivo studies showed that chronic treatment with the TRPV3 activators prevented adipogenesis and weight gain in the mice fed on high-fat diets. Moreover, TRPV3 expression was reduced in the visceral adipose tissue from mice fed on high-fat diets and obese (ob/ob) and diabetic (db/m(+)) mice. In conclusion, our study illustrates the antiadipogenic role of TRPV3 in the adipocytes.

Pubmed ID: 25774551 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Trpv3 monoclonal antibody, clone S15-4 (antibody)

RRID:AB_10681229

This monoclonal targets Trpv3 monoclonal antibody clone S15-4

View all literature mentions

FoxO1 (C29H4) Rabbit mAb (antibody)

RRID:AB_2106495

This monoclonal targets FoxO1 (C29H4) Rabbit mAb

View all literature mentions

GAPDH antibody [6C5] (antibody)

RRID:AB_2107448

This monoclonal targets GAPDH antibody [6C5]

View all literature mentions

IRS-2 (L1326) Antibody (antibody)

RRID:AB_2125771

This polyclonal targets IRS-2 (L1326)

View all literature mentions

PPAR-gamma (C26H12) Rabbit mAb (antibody)

RRID:AB_2166051

This monoclonal targets PPAR-gamma

View all literature mentions

Phospho-FoxO1 (Ser256) Antibody (antibody)

RRID:AB_329831

This polyclonal targets Phospho-FoxO1 (Ser256)

View all literature mentions

IRS-1 Antibody (antibody)

RRID:AB_330333

This polyclonal targets IRS-1

View all literature mentions

Phospho-IRS-1 (Ser307) Antibody (antibody)

RRID:AB_330342

This polyclonal targets Phospho-IRS-1 (Ser307)

View all literature mentions